• [1]  . Wnt-TCF7-SOX9 axis promotes cholangiocarcinoma proliferation and pemigatinib resistance in a FGF7-FGFR2 autocrine pathway.  Oncogene,  2885, 2022. 
• [2]  . BMI1 promotes cholangiocarcinoma progression and correlates with antitumor immunity in an exosome-dependent manner..  Cellular and molecular life sciences : CMLS,  79,  469, 2022. 
• [3]  . Aldehyde dehydrogenase 3B2 promotes the proliferation and invasion of cholangiocarcinoma by increasing Integrin Beta 1 expression.  Cell Death & Disease,  12,  2021. 
• [4]  . The Smad4-MYO18A-PP1A complex regulates beta-catenin phosphorylation and pemigatinib resistance by inhibiting PAK1 in cholangiocarcinoma.  Cell Death and Differentiation,  29,  818, 2022. 
• [5]  . Annexin10 promotes extrahepatic cholangiocarcinoma metastasis by facilitating EMT via PLA2G4A/PGE2/STAT3 pathway.  EBioMedicine,  47,  142, 2019. 
• [6]  . Transcription factor 7 promotes the progression of perihilar cholangiocarcinoma by inducing the transcription of c-Myc and FOS-like antigen 1.  EBioMedicine,  45,  181, 2019. 
• [7]  刘增利. Wnt-TCF7-SOX9 axis promotes cholangiocarcinoma proliferation and pemigatinib resistance in a FGF7-FGFR2 autocrine pathway.  Oncogene,  2022.